MedTrace Logo

Bioavailability of Insulin Administered in Duodenum

NCT00353990 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2007-04-25

No results posted yet for this study

Summary

A study of the bioavailability of insulin after infusion in the duodenum in healthy volunteers.

Conditions

Interventions

DRUG

Insulin Aspart

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Torben Laursen, MD, DMSc, Ph.D. · Department of Clinical Pharmacology, Aarhus Sygehus

  • Charlotte A Ihlo, MD · Department of Endocrinilogy, Universityhospital of Aarhus

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Completion
2006-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00353990 on ClinicalTrials.gov